Confirmatory interleukin-1 receptor antagonist trial in severe sepsisSteven M. Opal, Michael G. Seneff, Howard Levy et al.|Critical Care Medicine|1997Cited by 863
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebocontrolled multicenter trialCharles J. Fisher, Michael A. Catalano, Gus J. Slotman et al.|Critical Care Medicine|1994Cited by 490
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial*Daniel P. Schuster, John P. Pribble, Michael H. Metzler et al.|Critical Care Medicine|2003Cited by 82
A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsisMichael Luchi, Urosepsis Study Group, David C. Morrison et al.|Journal of Endotoxin Research|2000Cited by 38